{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12893107",
  "DateCompleted": {
    "Year": "2003",
    "Month": "09",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0006-3223",
      "JournalIssue": {
        "Volume": "54",
        "Issue": "3",
        "PubDate": {
          "Year": "2003",
          "Month": "Aug",
          "Day": "01"
        }
      },
      "Title": "Biological psychiatry",
      "ISOAbbreviation": "Biol Psychiatry"
    },
    "ArticleTitle": "Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment.",
    "Pagination": {
      "StartPage": "317",
      "EndPage": "329",
      "MedlinePgn": "317-29"
    },
    "Abstract": {
      "AbstractText": [
        "This article reviews the rapidly accumulating literature on the relationship between mood disorders and diabetes mellitus. Recent studies have demonstrated that depression and its associated symptoms constitute a major risk factor in the development of type 2 diabetes and may accelerate the onset of diabetes complications. Since the mid-1980s, multiple longitudinal and cross-sectional studies have scrutinized the association of diabetes with depressive symptoms and major depression. Utilizing the search terms depressive disorders, psychiatry, diabetes, and pathophysiology in MEDLINE searches (1966-2003), this article reviews studies investigating pathophysiological alterations related to glucose intolerance and diabetes in depressed patients. The few randomized, controlled studies of treatment of depression in patients with diabetes are also described. Short-term treatment of depression in patients with diabetes improves their dysphoria and other signs and symptoms of depression. Future research will confirm whether response to psychotherapy and/or psychopharmacologic treatment improves glucose control, encourages compliance with diabetes treatment, and perhaps even increases longevity."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA."
          }
        ],
        "LastName": "Musselman",
        "ForeName": "Dominique L",
        "Initials": "DL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Betan",
        "ForeName": "Ephi",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Larsen",
        "ForeName": "Hannah",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Phillips",
        "ForeName": "Lawrence S",
        "Initials": "LS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "DK063302",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "HS-07922",
        "Acronym": "HS",
        "Agency": "AHRQ HHS",
        "Country": "United States"
      },
      {
        "GrantID": "RR-00039",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S.",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Biol Psychiatry",
    "NlmUniqueID": "0213264",
    "ISSNLinking": "0006-3223"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Blood Glucose"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Blood Glucose"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "immunology",
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "complications",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [
        "physiopathology",
        "psychology"
      ],
      "DescriptorName": "Diabetes Mellitus, Type 1"
    },
    {
      "QualifierName": [
        "physiopathology",
        "psychology"
      ],
      "DescriptorName": "Diabetes Mellitus, Type 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ],
  "NumberOfReferences": "141"
}